- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Jeevan Scientific Technology's board approved Q2 & H1 FY26 financial results on Nov 12, 2025. For Q2, consolidated revenue hit ₹12.38 Cr with a net profit of ₹0.01 Cr. H1 consolidated revenue was ₹21.18 Cr, resulting in a net loss of ₹3.21 Cr.